Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL

NCT02717624

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Louisville, Kentucky, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site Hackensack, New Jersey, United States
  • Research Site Morristown, New Jersey, United States
View all 15 locations
View Trial Details
Active, not recruiting

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

NCT04754945

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • University of California Orange, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, not recruiting

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

NCT06097832

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Sutter Health Alta Bates Berkeley, California, United States
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 18 locations
View Trial Details
Active, not recruiting

TmCD19-IL18 in CD19+ Cancers

NCT05989204

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions